Compare RAYMED LABS. with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RAYMED LABS vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    RAYMED LABS PANACEA BIOTECH RAYMED LABS/
PANACEA BIOTECH
 
P/E (TTM) x -5.4 -6.1 - View Chart
P/BV x - - - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 RAYMED LABS   PANACEA BIOTECH
EQUITY SHARE DATA
    RAYMED LABS
Mar-20
PANACEA BIOTECH
Mar-21
RAYMED LABS/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs3265 1.1%   
Low Rs1110 0.9%   
Sales per share (Unadj.) Rs0102.0 0.0%  
Earnings per share (Unadj.) Rs-0.1-24.1 0.5%  
Cash flow per share (Unadj.) Rs-0.1-16.6 0.7%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-4.6-37.3 12.4%  
Shares outstanding (eoy) m4.2761.25 7.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio xNM1.8-  
Avg P/E ratio x-14.8-7.8 190.1%  
P/CF ratio (eoy) x-16.6-11.3 146.6%  
Price / Book Value ratio x-0.4-5.0 8.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m811,498 0.1%   
No. of employees `000NANA-   
Total wages/salary Rs m01,563 0.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m06,248 0.0%  
Other income Rs m0106 0.1%   
Total revenues Rs m06,354 0.0%   
Gross profit Rs m-1757 -0.1%  
Depreciation Rs m0461 0.0%   
Interest Rs m01,853 0.0%   
Profit before tax Rs m-1-1,451 0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m026 0.0%   
Profit after tax Rs m-1-1,477 0.0%  
Gross profit margin %NM12.1- 
Effective tax rate %0-1.8 0.0%   
Net profit margin %NM-23.6- 
BALANCE SHEET DATA
Current assets Rs m15,110 0.0%   
Current liabilities Rs m225,959 0.4%   
Net working cap to sales %NM-13.6- 
Current ratio x00.9 4.7%  
Inventory Days DaysNM114- 
Debtors Days DaysNM49- 
Net fixed assets Rs m28,379 0.0%   
Share capital Rs m4361 69.8%   
"Free" reserves Rs m-63-2,348 2.7%   
Net worth Rs m-20-2,287 0.9%   
Long term debt Rs m07,351 0.0%   
Total assets Rs m313,489 0.0%  
Interest coverage xNM0.2-  
Debt to equity ratio x0-3.2 0.0%  
Sales to assets ratio x00.5 0.0%   
Return on assets %-21.72.8 -777.1%  
Return on equity %2.864.6 4.3%  
Return on capital %2.87.9 35.3%  
Exports to sales %NM34.8-  
Imports to sales %NM9.0-  
Exports (fob) Rs mNA2,176 0.0%   
Imports (cif) Rs mNA560 0.0%   
Fx inflow Rs m02,270 0.0%   
Fx outflow Rs m0657 0.0%   
Net fx Rs m01,613 0.0%   
CASH FLOW
From Operations Rs m01,068 0.0%  
From Investments Rs mNA-477 0.0%  
From Financial Activity Rs mNA-471 0.0%  
Net Cashflow Rs m0119 0.0%  

Share Holding

Indian Promoters % 28.4 73.6 38.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.0 0.4 228.6%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 71.6 26.4 271.3%  
Shareholders   1,428 52,816 2.7%  
Pledged promoter(s) holding % 0.0 94.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare RAYMED LABS With:   ADVANCED ENZYME TECHNOLOGIES  VISTA PHARMA  STRIDES PHARMA SCIENCE  AVON ORGANIC  UNICK FIX-A-FORM AND PRINTERS  



Today's Market

4 Reasons Why Sensex Surged 1,016 Points Today(Closing)

Indian share markets continued their momentum and ended their day on a strong note today.

Related Views on News

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

6 Penny Stocks that Rallied 1,000%+ in One Year(Views On News)

Dec 6, 2021

These penny stocks shed their penny status by surging 1,000% or more in the last one year.

The Biggest Winners and Losers in India's Transition to Electric Vehicles(Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

RAYMED LABS SHARE PRICE


Dec 6, 2021 (Close)

TRACK RAYMED LABS

  • Track your investment in RAYMED LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

RAYMED LABS 8-QTR ANALYSIS

COMPARE RAYMED LABS WITH

MARKET STATS